Clinical and molecular characteristics of multi-clone carbapenem-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in a tertiary hospital in Beijing, China

International Journal of Infectious Diseases

Volumn 37, Issue , 2015, Pages 107-112

  Yao, Bei ^a   Xiao, Xiumei ^a   Wang, Fei ^a   Zhou, Lei ^a   Zhang, Xiaowei ^a   Zhang, Jie ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Carbapenem resistant; Hypermucoviscous; Hypervirulent; Klebsiella pneumoniae

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT HYPERVIRULENT HYPERMUCOVISCOUS KLEBSIELLA PNEUMONIAE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; KLEBSIELLA PNEUMONIAE; KPC 2 GENE; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; SEROTYPE; TERTIARY CARE CENTER; AGED; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; FEMALE; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MALE; MICROBIOLOGY; PATHOGENICITY; VERY ELDERLY; VIRULENCE;

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BEIJING; CARBAPENEMS; CHINA; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; VIRULENCE;

EID: 84937795759     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2015.06.023     Document Type: Article

References (38)

1. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11:589-603.
2. Liu Y.C., Cheng D.L., Lin C.L. Klebsiella pneumoniae liver abscess associated with septic endophthalmitis. Arch Intern Med 1986, 146:1913-1916.
3. Buppajarntham S., Shah M., Junpaparp P. Tumor-like pyogenic liver abscess caused by Klebsiella pneumoniae in diabetes. Endocrine 2014, 47:656-657.
4. Vila A., Cassata A., Pagella H., Amadio C., Yeh K.M., Chang F.Y., et al. Appearance of Klebsiella pneumoniae liver abscess syndrome in Argentina: case report and review of molecular mechanisms of pathogenesis. Open Microbiol J 2011, 5:107-113.
5. Gundestrup S., Struve C., Stahlhut S.G., Hansen D.S. First case of liver abscess in Scandinavia due to the international hypervirulent Klebsiella pneumoniae clone ST23. Open Microbiol J 2014, 8:22-24.
6. Hyun J.I., Kim Y.J., Jeon Y.H., Kim S.I., Park Y.J., Kang M.W., et al. A case of ventriculitis associated with renal abscess caused by serotype K1 Klebsiella pneumoniae. Infect Chemother 2014, 46:120-124.
7. Vandevelde A., Stepanovic B. On a boat: a case in Australia of endophthalmitis and pyogenic liver, prostatic, and lung abscesses in a previously well patient due to Klebsiella pneumoniae. Case Rep Infect Dis 2014, 2014:137248.
8. Siu L.K., Yeh K.M., Lin J.C., Fung C.P., Chang F.Y. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis 2012, 12:881-887.
9. Fang C.T., Chuang Y.P., Shun C.T., Chang S.C., Wang J.T. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J Exp Med 2004, 199:697-705.
10. Kawai T. Hypermucoviscosity: an extremely sticky phenotype of Klebsiella pneumoniae associated with emerging destructive tissue abscess syndrome. Clin Infect Dis 2006, 42:1359-1361.
11. Pomakova D.K., Hsiao C.B., Beanan J.M., Olson R., MacDonald U., Keynan Y., et al. Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. Eur J Clin Microbiol Infect Dis 2012, 31:981-989.
12. Li W., Sun G., Yu Y., Li N., Chen M., Jin R., et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis 2014, 58:225-232.
13. Yigit H., Queenan A.M., Anderson G.J., Domenech-Sanchez A., Biddle J.W., Steward C.D., et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45:1151-1161.
14. Villegas M.V., Lolans K., Correa A., Suarez C.J., Lopez J.A., Vallejo M., Quinn J.P. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 2006, 50:2880-2882. Colombian Nosocomial Resistance Study Group.
15. Leavitt A., Navon-Venezia S., Chmelnitsky I., Schwaber M.J., Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007, 51:3026-3029.
16. Wei Z.Q., Du X.X., Yu Y.S., Shen P., Chen Y.G., Li L.J. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007, 51:763-765.
17. Carmeli Y., Akova M., Cornaglia G., Daikos G.L., Garau J., Harbarth S., et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010, 16:102-111.
18. Zarkotou O., Pournaras S., Tselioti P., Dragoumanos V., Pitiriga V., Ranellou K., et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011, 17:1798-1803.
19. Cejas D., Fernandez Canigia L., Rincon Cruz G., Elena A.X., Maldonado I., Gutkind G.O., et al. First isolate of KPC-2-producing Klebsiella pneumoniae sequence type 23 from the Americas. J Clin Microbiol 2014, 52:3483-3485.
20. Andrade L.N., Vitali L., Gaspar G.G., Bellissimo-Rodrigues F., Martinez R., Darini A.L. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol 2014, 52:2530-2535.
21. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
22. Lee H.C., Chuang Y.C., Yu W.L., Lee N.Y., Chang C.M., Ko N.Y., et al. Clinical implications of hypermucoviscosity phenotype in Klebsiella pneumoniae isolates: association with invasive syndrome in patients with community-acquired bacteraemia. J Intern Med 2006, 259:606-614.
23. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement. Document M100-S22. Wayne, PA: CLSI; 2012.
24. Pillar C.M., Draghi D.C., Dowzicky M.J., Sahm D.F. In vitro activity of tigecycline against Gram-positive and Gram-negative pathogens as evaluated by broth microdilution and Etest. J Clin Microbiol 2008, 46:2862-2867.
25. Poirel L., Walsh T.R., Cuvillier V., Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011, 70:119-123.
26. Fang C.T., Lai S.Y., Yi W.C., Hsueh P.R., Liu K.L., Chang S.C. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 2007, 45:284-293.
27. Brisse S., Fevre C., Passet V., Issenhuth-Jeanjean S., Tournebize R., Diancourt L., et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 2009, 4:e4982.
28. Lafeuille E., Decre D., Mahjoub-Messai F., Bidet P., Arlet G., Bingen E. OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients. Microb Drug Resist 2013, 19:491-497.
29. Tang H.L., Chiang M.K., Liou W.J., Chen Y.T., Peng H.L., Chiou C.S., et al. Correlation between Klebsiella pneumoniae carrying pLVPK-derived loci and abscess formation. Eur J Clin Microbiol Infect Dis 2010, 29:689-698.
30. Han H., Zhou H., Li H., Gao Y., Lu Z., Hu K., et al. Optimization of pulse-field gel electrophoresis for subtyping of Klebsiella pneumoniae. Int J Environ Res Public Health 2013, 10:2720-2731.
31. Tenover F.C., Arbeit R.D., Goering R.V., Mickelsen P.A., Murray B.E., Persing D.H., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
32. Luo Y., Wang Y., Ye L., Yang J. Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 2014, 20:O818-O824.
33. Jung S.W., Chae H.J., Park Y.J., Yu J.K., Kim S.Y., Lee H.K., et al. Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea. Epidemiol Infect 2013, 141:334-340.
34. Siu L.K., Huang D.B., Chiang T. Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae. BMC Infect Dis 2014, 14:176.
35. Qi Y., Wei Z., Ji S., Du X., Shen P., Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011, 66:307-312.
36. Satlin M.J., Kubin C.J., Blumenthal J.S., Cohen A.B., Furuya E.Y., Wilson S.J., et al. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine. Antimicrob Agents Chemother 2011, 55:5893-5899.
37. Lin J.C., Koh T.H., Lee N., Fung C.P., Chang F.Y., Tsai Y.K., et al. Genotypes and virulence in serotype K2 Klebsiella pneumoniae from liver abscess and non-infectious carriers in Hong Kong, Singapore and Taiwan. Gut Pathog 2014, 6:21.
38. Liu Y.M., Li B.B., Zhang Y.Y., Zhang W., Shen H., Li H., et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother 2014, 58:5379-5385.